Healthcare Of Ontario Pension Plan Trust Fund Cerevel Therapeutics Holdings, Inc. Transaction History

Healthcare Of Ontario Pension Plan Trust Fund

$45.5 Billion
Q4 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$38.96 - $42.75 $14.1 Million - $15.5 Million	-361,953 Reduced 43.67%	466,823 $19.1 Million
Q1 2024 May 13, 2024	BUY	$40.88 - $43.27 $20.4 Million - $21.6 Million	498,776 Added 151.14%	828,776 $35 Million
Q4 2023 Mar 21, 2024	BUY	$20.27 - $42.44 $6.69 Million - $14 Million	330,000 New	330,000 $14 Million
Q4 2021 Feb 11, 2022	SELL	$29.21 - $44.64 $5.68 Million - $8.68 Million	-194,400 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$21.26 - $38.85 $4.13 Million - $7.55 Million	194,400 New	194,400 $5.74 Million

Others Institutions Holding CERE

# of Institutions

Shares Held

5.01M

Call Options Held

3.3K

Put Options Held

View Full List

About Cerevel Therapeutics Holdings, Inc.

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

More about CERE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.

Account